SYMPHOMAX

Serial Number 85193730
602

Registration Progress

Application Filed
Dec 8, 2010
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: SYMPHOMAX
Previous Owner: Kyowa Hakko Kirin Co., Ltd.
Classes: 005, 040, 042

Trademark Image

SYMPHOMAX

Basic Information

Serial Number
85193730
Filing Date
December 8, 2010
Abandonment Date
February 26, 2013
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Mar 22, 2013
Classes
005 040 042

Rights Holder

Kyowa Hakko Kirin Co., Ltd.

03
Address
6-1, Ohtemachi 1-chome, Chiyoda-ku
Tokyo
JP

Ownership History

Kyowa Hakko Kirin Co., Ltd.

Original Applicant
03
Tokyo JP

Legal Representation

Attorney
Kaushal R. Odedra

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

27 events
Date Code Type Description Documents
Mar 22, 2013 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Mar 22, 2013 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Aug 24, 2012 CNRT O NON-FINAL ACTION MAILED Loading...
Aug 24, 2012 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 9, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 8, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 10, 2012 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 9, 2012 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 9, 2012 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 27, 2011 CNRT O NON-FINAL ACTION MAILED Loading...
Dec 24, 2011 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 23, 2011 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 22, 2011 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 22, 2011 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Nov 22, 2011 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Nov 16, 2011 CNSL S LETTER OF SUSPENSION MAILED Loading...
Nov 15, 2011 CNSL R SUSPENSION LETTER WRITTEN Loading...
Oct 7, 2011 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 7, 2011 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 29, 2011 ALIE A ASSIGNED TO LIE Loading...
Sep 20, 2011 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 21, 2011 CNRT F NON-FINAL ACTION MAILED Loading...
Mar 21, 2011 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 12, 2011 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 14, 2010 MPMK O NOTICE OF PSEUDO MARK MAILED Loading...
Dec 13, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 11, 2010 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use; antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, pharmaceutical preparations for the treatment of insomnia and other sleep related diseases
First Use Anywhere: 0
First Use in Commerce: 0
Class 040
Contract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of host cells; contract extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; providing information in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of host cells; technical consultation in the field of manufacturing technology in the field of host cells; providing technical information in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals technical consultation in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Development of new products for others in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; providing technical information in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; technical consultation in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
SYMPHONY MAX

Classification

International Classes
005 040 042